CEO · PFE
CEO$Executive Intelligence
Albert Bourla
Chairman & CEO · Pfizer PFE
$27.6M
FY2025 total compensation
Filed · DEF 14AThe veterinarian-turned-CEO who led Pfizer’s COVID-19 vaccine effort and now steers the drugmaker through the post-pandemic slump.
CEO since2019
Born1961
Pay rank#32 of 50 tracked
Pay vs performance
what happened while he earned itCEO compensation$27.6M
Stock · since 2024-13.3%
S&P 500 · since 2024+37.4%
Revenue · YoY-1.6%
EPS · YoY-3.5%
CEO tenure7 yrs
No score, no opinion. Compensation is filed; stock and S&P are market returns over the window shown; revenue and EPS are latest reported vs the prior year. You decide.
Why this pay?
- His fiscal 2025 Summary Compensation Table total was $27.6 million, roughly 92% performance-based — a mix of salary, cash incentive, and the grant value of stock and options — equal to about 277 times the company’s median employee pay.
Quick facts
CEO since2019
PreviouslyPfizer
Largest pay componentStock & options · 67%
Pay rank (tracked)#32 of 50
EducationAristotle University of Thessaloniki (DVM; PhD, Reproductive Biotechnology)
Compensation breakdown
DEF 14Atotal · FY2025$27,581,287
Salary$1,800,000
Cash incentive$5,400,000
Stock awards$9,442,705
Option awards$8,998,141
All other comp$1,940,441
Total$27,581,287
~92% performance-based; ~277x the median employee. Source: Pfizer 2026 Proxy (FY2025) →
Compensation history
salary + cash vs stock, from the proxies$24.6MFY2024
$27.6MFY2025
Stock & optionsSalary & cashOther
Related intelligence
every filing on Pfizer, one hop awayCareer
Compare pay with
Every figure ties to a filing. Compensation is the total from Pfizer's Summary Compensation Table for FY2025(grant-date values, which can differ from what an executive realizes when awards vest). We publish what the filings say, and we don't grade people. Photo: World Economic Forum / CC BY 3.0 / Wikimedia Commons.